Overactive Bladder

Neuromodulation techniques for managing overactive bladder. May 31, 2026

Association between hepatitis C virus and overactive bladder: a cross-sectional study based on the 2013-2018 NHANES. May 31, 2026

Chinese American Women's Overactive Bladder Care Experience: A Qualitative Study. May 24, 2026

Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study. May 24, 2026

Overactive Bladder 5 Years After the Mid-Urethral Sling Tensioning (MUST) Trial. May 18, 2026

METS-VF outperforms traditional adiposity indices in predicting overactive bladder risk: a NHANES-based cross-sectional study. May 17, 2026

Exploring the association between weight-adjusted-waist index and overactive bladder: A population-based study. May 17, 2026

Blood pressure increases and other safety and medication compliance in overactive bladder patients treated with Selebeta® PR tablets: A noninterventional, multicenter, retrospective observational study. May 10, 2026

Health Disparities and Overactive Bladder: Bridging the Gap. May 3, 2026

Efficacy and safety of mirabegron versus solifenacin in the treatment of overactive bladder in children: a systematic review and meta-analysis. April 26, 2026

Prevalence and risk factors of overactive bladder syndrome among Egyptian medical students, and its impact on health-related quality of life, cross-sectional study. May 31, 2026

Impact of Adjunctive Myo-Inositol and Magnesium Therapy on Paediatric Overactive Bladder: A Retrospective Analysis. May 31, 2026

Decision-Making in Refractory Overactive Bladder: Evaluation of a Novel Patient Decision Aid and its Impact on Decisional Conflict. May 24, 2026

The Overactive and Poorly Compliant Bladder: a Review of Coexisting Detrusor Overactivity and Poor Compliance May 18, 2026

The Relationship Between Urinary Caffeine With Caffeine Metabolites and Wet Overactive Bladder: A Cross-Sectional Study From NHANES 2009-2014 Data. May 17, 2026

Endoscopic Topical Application (ETA) Therapy for Refractory Overactive Bladder: A First-in-Human Report. May 17, 2026

Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database Analysis. May 10, 2026

Long-term safety of overactive bladder medications in men receiving pharmacotherapy for benign prostatic enlargement: a real-world study using inverse probability of treatment weighting. May 10, 2026

Efficacy and Safety of Mirabegron in Frail Older Adults with Overactive Bladder. May 3, 2026

Outcomes following intradetrusor onabotulinumtoxinA injections and sacral neuromodulation in older men. April 26, 2026

Page 1 of 139